Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Total 13F shares
-
5,709,266
-
Share change
-
-5,418,983
-
Total reported value
-
$3,367,239
-
Price per share
-
$0.59
-
Number of holders
-
15
-
Value change
-
-$4,319,874
-
Number of buys
-
5
-
Number of sells
-
17
Institutional Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q4 2022
As of 31 Dec 2022,
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,709,266 shares.
The largest 10 holders included
Altium Capital Management LP, SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, LPL Financial LLC, Atria Wealth Solutions, Inc., GEODE CAPITAL MANAGEMENT, LLC, Geneos Wealth Management Inc., Cutter & CO Brokerage, Inc., and Belpointe Asset Management LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.